NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle ...

Yale researchers have developed a new and safe family of RNA-editing tools that utilize an RNA-targeting activity that they ...

Webcasts will be available on the Caribou website for at least 30 days after the event. About Caribou Biosciences, Inc. Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical ...

Tiny "hidden" proteins lurking in DNA once dismissed as junk may hold the key to the next generation of obesity drugs, ...

There's a fresh push to edit the genes of human embryos to prevent diseases and enhance characteristics that parents value.

Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing function. These preclinical findings could ...

They used CRISPR-Cas9 gene-editing technology to “knock out” these genes in several tomato varieties. The results were impressive. Sugar levels, particularly glucose and fructose, increased by ...

Gene editing is growing up. Ten years after Science magazine named CRISPR its 2015 “ Breakthrough of the Year,” this revolutionary gene editing technology has become a workhorse of modern biology.

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic research and therapeutic applications.

CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel Prize-winning CRISPR/Cas9 gene editing technology. While CRSP is the first and ...